Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.660
+0.040 (1.10%)
Apr 10, 2026, 11:57 AM EDT - Market open
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $56.63 million as of April 10, 2026. Its market cap has increased by 117.83% in one year.
Market Cap
56.63M
Enterprise Value
37.34M
1-Year Change
117.83%
Ranking
Category
Stock Price
$3.66
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $56.63M, a decrease of -99.17%. That is a compound annual growth rate of -34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 56.00M | 14.52% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kezar Life Sciences | 54.48M |
| Edesa Biotech | 53.76M |
| ImageneBio | 53.13M |
| Mereo BioPharma Group | 52.16M |
| OS Therapies | 51.71M |
| Radiopharm Theranostics | 51.63M |
| PDS Biotechnology | 51.24M |
| Metagenomi Therapeutics | 51.16M |